Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Lancor Scientific researches in Austria

Lancor Scientific Chief Medical Officer und Prokurtist Prof. Dr. Roland Schlesinger ©

The method should provide 90 percent accuracy, whereas the precision of conventional Pap tests is only 60-70 percent. A research laboratory was set up in Graz for further research on the patented Opto-magnetic Imaging Spectroscopy (OMIS) process. The company cooperates with the Graz University of Technology, the Medical University of Graz and Sigmund Freud University in Vienna. Lancor established a subsidiary in Austria for this purpose. Research will be supported by public funding over a period of five years. The device itself is expected to be already launched on the marketplace in 2019. The company hopes to have 10,000 devices available in the next five years.  

 “Identifying cancer at an early stage is the key to save lives. Lancor Scientific has set itself the task of making an accurate and cost-effective cancer identification technology available around the world. The confidence placed in us by the Austrian government and the partnership with specialists at the Graz University of Technology form the basis for continuing this journey and making a minimum of 10,000 devices available over the next five years. In this case, 500,000 cancer tests can be carried out each day”, says Chief Medical Officer at Lancor Scientific Schlesinger Roland.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Specialist seminar Invest in Austria "Research and foundation of companies in Austria"

    29.01.2019, Zürich, Schweiz

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

The so-called CAR-T cell therapy is a promising option for treating around one fifth of patients with diffuse large B-cell lymphoma.

Ski Tourism as an Attractive Business Driver in Austria

Famous for its culture and unspoiled natural environment, Austria attracts vacationers and tourism companies from all over the world. One major advantage is the central location in the heart of Europe and the related good accessibility.

More news All blog posts